Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis
- PMID: 16749897
- DOI: 10.1615/critreveukargeneexpr.v16.i2.60
Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis
Abstract
The hematopoietic stem cell (HSC) has the potential to differentiate into mature cells with distinct phenotypes and functions. As suggested in recent reports, this plasticity can expand to include nonhematopoietic lineages, and, indeed, the HSC may repopulate liver and muscle tissues, as well. Considering the flexibility in HSC differentiation, these processes are regulated by a relatively small number of factors, some of which are expressed in all lineages, whereas others are activated only in a specific cell type. Combined evidence from many studies suggests that alternative subsets of these factors work in a combinatorial manner to regulate specific promoters for the induction of a specific lineage. RUNX1 and PU.1 have a fundamental role in HSC differentiation in that multifactor complexes are assembled around these proteins leading to tissue-specific and synergistic gene activation. Here we describe the relationship of RUNX1 with PU.1 as a facet of the combinatorial relationships that determine hematopoietic lineage commitment.
Similar articles
-
Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.J Cell Biochem. 2005 Nov 1;96(4):795-809. doi: 10.1002/jcb.20548. J Cell Biochem. 2005. PMID: 16149049
-
Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.Stem Cells Dev. 2005 Apr;14(2):140-52. doi: 10.1089/scd.2005.14.140. Stem Cells Dev. 2005. PMID: 15910240 Review.
-
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.Genes Dev. 1998 Aug 1;12(15):2403-12. doi: 10.1101/gad.12.15.2403. Genes Dev. 1998. PMID: 9694804 Free PMC article.
-
Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.J Biol Chem. 2014 May 23;289(21):14881-95. doi: 10.1074/jbc.M114.562447. Epub 2014 Apr 2. J Biol Chem. 2014. PMID: 24695740 Free PMC article.
-
The RUNX1-PU.1 axis in the control of hematopoiesis.Int J Hematol. 2015 Apr;101(4):319-29. doi: 10.1007/s12185-015-1762-8. Epub 2015 Mar 8. Int J Hematol. 2015. PMID: 25749719 Review.
Cited by
-
Phase separation participates in the genetic regulation mechanism of hematopoietic stem cells: potential therapeutic methods.Stem Cell Res Ther. 2025 May 1;16(1):214. doi: 10.1186/s13287-025-04350-1. Stem Cell Res Ther. 2025. PMID: 40312729 Free PMC article. Review.
-
RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.Blood. 2010 Apr 15;115(15):3128-35. doi: 10.1182/blood-2009-04-214601. Epub 2010 Feb 24. Blood. 2010. PMID: 20181616 Free PMC article.
-
A computational evaluation of over-representation of regulatory motifs in the promoter regions of differentially expressed genes.BMC Bioinformatics. 2010 May 20;11:267. doi: 10.1186/1471-2105-11-267. BMC Bioinformatics. 2010. PMID: 20487530 Free PMC article.
-
The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.J Cell Physiol. 2010 Nov;225(2):569-76. doi: 10.1002/jcp.22240. J Cell Physiol. 2010. PMID: 20506188 Free PMC article.
-
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.Cancer Res. 2015 Mar 15;75(6):924-9. doi: 10.1158/0008-5472.CAN-14-3225. Epub 2015 Jan 20. Cancer Res. 2015. PMID: 25604264 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials